Literature DB >> 8890233

Balance of inflammatory cytokines related to severity and mortality of murine sepsis.

K R Walley1, N W Lukacs, T J Standiford, R M Strieter, S L Kunkel.   

Abstract

We tested the hypothesis that, during sepsis, the balance of pro- and anti-inflammatory cytokines is related to severity and survival. Cecal ligation and puncture (CLP) with a large (18-gauge)-, intermediate (21-gauge)-, or small (26-gauge)-diameter needle, or sham laparotomy, was performed on outbred CD-1 mice. Concentrations of tumor necrosis factor alpha (TNF-alpha), interleukin-6 (IL-6), and the anti-inflammatory cytokine IL-10 were measured (by enzyme-linked immunosorbent assay) in serum, peritoneal lavage fluid, and liver and lung samples at 4, 8, 24, 48, and 96 h. As the diameter of the CLP needle decreased, the mortality rate decreased (at 48 h: large, 80%; intermediate, 40%; small, 20%; P < 0.05), the TNF-alpha and IL-6 concentrations decreased, and the time-to-peak TNF-alpha expression increased. In contrast, IL-10 concentration increased compared with baseline (serum at 24 h: large, 2.3-fold +/- 1.6-fold; intermediate, 2.0-fold +/- 0.5-fold; small, 49.9-fold +/- 8.3-fold; P < 0.05). Administration of IL-10 (5 microg, intraperitoneal) prior to CLP decreased mortality (P < 0.001). Administration of polyclonal anti-IL-10 serum prior to CLP (0.5 ml intraperitoneal) had the opposite effect and increased mortality (P < 0.001) and TNF-alpha, IL-6, and TNF-alpha mRNA expression compared with controls. Thus, severe sepsis is associated with a largely unopposed inflammatory response, and a largely unopposed inflammatory response (with anti-IL-10) results in severe sepsis and death. Less severe sepsis is associated with greater anti-inflammatory mediator expression, and greater anti-inflammatory mediator expression (with IL-10) results in less severe sepsis. Thus, the balance of inflammatory mediators is related to the severity and mortality of murine sepsis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8890233      PMCID: PMC174439          DOI: 10.1128/iai.64.11.4733-4738.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  The response of the IL-6-dependent cell line, B9, to IL-6 is not augmented by recombinant derived purified IL-2.

Authors:  P J Morrissey; T Sato; S Braddy
Journal:  J Immunol Methods       Date:  1992-02-14       Impact factor: 2.303

2.  Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis.

Authors:  B Echtenacher; W Falk; D N Männel; P H Krammer
Journal:  J Immunol       Date:  1990-12-01       Impact factor: 5.422

3.  Cytokine serum level during severe sepsis in human IL-6 as a marker of severity.

Authors:  P Damas; D Ledoux; M Nys; Y Vrindts; D De Groote; P Franchimont; M Lamy
Journal:  Ann Surg       Date:  1992-04       Impact factor: 12.969

4.  Negative inotropic effects of cytokines on the heart mediated by nitric oxide.

Authors:  M S Finkel; C V Oddis; T D Jacob; S C Watkins; B G Hattler; R L Simmons
Journal:  Science       Date:  1992-07-17       Impact factor: 47.728

Review 5.  Interleukin-10.

Authors:  K W Moore; A O'Garra; R de Waal Malefyt; P Vieira; T R Mosmann
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

6.  Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis.

Authors:  G J Bagby; K J Plessala; L A Wilson; J J Thompson; S Nelson
Journal:  J Infect Dis       Date:  1991-01       Impact factor: 5.226

7.  Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome.

Authors:  L C Casey; R A Balk; R C Bone
Journal:  Ann Intern Med       Date:  1993-10-15       Impact factor: 25.391

8.  Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia.

Authors:  M K Eskandari; G Bolgos; C Miller; D T Nguyen; L E DeForge; D G Remick
Journal:  J Immunol       Date:  1992-05-01       Impact factor: 5.422

9.  Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.

Authors:  C Gérard; C Bruyns; A Marchant; D Abramowicz; P Vandenabeele; A Delvaux; W Fiers; M Goldman; T Velu
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

10.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.

Authors:  R de Waal Malefyt; J Abrams; B Bennett; C G Figdor; J E de Vries
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

View more
  114 in total

1.  Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis.

Authors:  F Arnalich; E Garcia-Palomero; J López; M Jiménez; R Madero; J Renart; J J Vázquez; C Montiel
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

Review 2.  Sepsis-induced immunosuppression: from bad to worse.

Authors:  R C Reddy; G H Chen; P K Tekchandani; T J Standiford
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

3.  Novel protective effects of stem cell factor in a murine model of acute septic peritonitis. Dependence on MCP-1.

Authors:  C L Bone-Larson; C M Hogaboam; M L Steinhauser; S H Oliveira; N W Lukacs; R M Strieter; S L Kunkel
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

4.  Long-term dynamic profiling of inflammatory mediators in double-hit burn and sepsis animal models.

Authors:  Mehmet A Orman; Marianthi G Ierapetritou; Francois Berthiaume; Ioannis P Androulakis
Journal:  Cytokine       Date:  2012-03-07       Impact factor: 3.861

5.  Septic mice are susceptible to pulmonary aspergillosis.

Authors:  Claudia F Benjamim; Cory M Hogaboam; Nicholas W Lukacs; Steven L Kunkel
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

6.  Effects of Aging on Inflammation and Hemostasis through the Continuum of Critical Illness.

Authors:  Sachin S Kale; Sachin Yende
Journal:  Aging Dis       Date:  2011-12-02       Impact factor: 6.745

7.  Compound 9a, a novel synthetic histone deacetylase inhibitor, protects against septic injury in mice by suppressing MAPK signalling.

Authors:  So-Jin Kim; Ki Seon Baek; Hyun-Ju Park; Young Hoon Jung; Sun-Mee Lee
Journal:  Br J Pharmacol       Date:  2016-02-22       Impact factor: 8.739

8.  Sepsis-induced changes in macrophage co-stimulatory molecule expression: CD86 as a regulator of anti-inflammatory IL-10 response.

Authors:  Sarah Newton; Yanli Ding; Chun-Shiang Chung; Yaping Chen; Joanne L Lomas-Neira; Alfred Ayala
Journal:  Surg Infect (Larchmt)       Date:  2004       Impact factor: 2.150

9.  Seprafilm does not aggravate intraperitoneal septic conditions or evoke systemic inflammatory response.

Authors:  Keiichi Uchida; Hisashi Urata; Yasuhiko Mohri; Mikihiro Inoue; Chikao Miki; Masato Kusunoki
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

10.  Interleukin-10 polymorphism in position -1082 and acute respiratory distress syndrome.

Authors:  M N Gong; B T Thompson; P L Williams; W Zhou; M Z Wang; L Pothier; D C Christiani
Journal:  Eur Respir J       Date:  2006-04       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.